15
Views
3
CrossRef citations to date
0
Altmetric
Review

Emerging therapeutic cell wall targets in fungal infections

&
Pages 53-72 | Published online: 25 Feb 2005

Bibliography

  • HERBRECHT R: The changing epidemiology of fungal infections: Are the lipid-based forms of amphotericin B an advance? Eur. J. Haematol. (1996) 56:12–17.
  • COX G, PERFECT J: Fungal Infections. Curr. Opin. Infect. Dis. (1993) 6:422–426.
  • FOX JL: Fungal infection rates are increasing. ASMNews (1993) 59:515–518.
  • ALEXANDER BD, PERFECT JR: Antifungal resistancetrends towards the year 2000-Implications for therapy and new approaches. Drugs (1997) 54:657–678.
  • BOW EJ: Invasive fungal infections in patients receiv-ing intensive cytotoxic therapy for cancer. Br. J. Hae-mato] (1998) 101:1–4.
  • WARNOCK DW: Fungal infections in neutropenia: cur-rent problems and chemotherapeutic control. J. Anti-microb. Chemother. (1998) 41:95–105.
  • Centers for Disease Control: http ://www.cdc.gov/ncidod/publications/ brochures/hip .htm
  • BECK-SAGUE CM, JARVIS WR, THE NATIONAL NOSO-COMIAL INFECTIONS SURVEILLANCE SYSTEM: Secular trends in the epidemiology of nosocomial fungal in-fections in the United States, 1980-1990. J. Infect. Dis. (1993) 167:1247-1251.HIV/AIDS Surveillance Report (Year-End Edition). (1996) 7(2).
  • HIV/AIDS Surveillance Report (Year-End Edition). (1996) 7(2).
  • HOOD S, DENNING DW: Treatment of fungal infection in AIDS. J. Antimicrob. Chemother. (1996) 37:71–85.
  • ROSENBERG P: Scope of the AIDS epidemic in the United States. Science (1995) 270:1372–1375.
  • CAIRNS MR: Fungal infections in the acquired immunodeficiency syndrome. J. Electron. Microsc. Tech. (1988) 8:115–131.
  • POLIS MA, KOVACS JA: Fungal infections in patients with the acquired immunodeficiency syndrome. In: AIDS: Biology, Diagnosis, Treatment and Prevention (Edi-tion 4). DeVita Jr. VT, Hellman S, Rosenberg SA (Eds.), Lippincott-Raven (1997).
  • AMPEL NM: Emerging Disease Issues and Fungal Patho-gens Associated with HIV Infection. Emer. Infect. Dis. (1996) 2:109–116.
  • GALLIS H, DREW R, PICKARD W: Amphotericin B: 30 years of clinical experience. Rev. Inf. Dis. (1990) 12:308–329.
  • GRAYBILL JR: The Future of Antifungal Therapy. Clin. Infect. Dis. (1996) 22 (Suppl. 2):S166–S178.
  • BOSCHMAN CR, BODMAR UR, TORNATORE MA et al.: Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. Antimicrob. Agents Chemother. (1998) 42:734–738.
  • DENNING DW: Echinocandins and Pneumocandins-a new antifungal class with a novel mode of action. J. An-timicrob. Chemother. (1997) 40:611–614.
  • OKI T, MASATAKA K, TOMATSU K et al.: Pradimicin, a novel class of potent antifungal antibiotics. J. AntibioL (Tokyo) (1998) 41:1701–1704.
  • WALSH T, GIRI N: Pradimicins: a novel class of broad-spectrum antifungal compounds. Eur. J. Clin. Microbiol. Infect. Dis. (1997) 16:93–97.
  • DOMINGUEZ J, MARTIN J: Identification of elongation factor 2 as the essential protein targeted by sordarins. Antimicrob. Agents Chemother. (1998) 42:2269–2278.
  • HERREROS E, MARTINEZ C, ALMELA M et al. Sordarins:In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii and filamen-tous fungi. Antimicrob. Agents Chemother. (1998) 42:2863–2869.
  • DECKER H, ZAHNER H, HEITSCH H, KONIG W, FIEDLER H: Structure-activity relationships of the nikkomycins. J. Gen. Microbic)] (1991) 137:1805–1813.
  • The Discovery of Natural Products with Therapeutic Potential. Gullo VP (Ed.), Butterworth-Heinemann, Boston, USA (1994).
  • SHU Y-Z: Recent Natural Products Based Drug Develop-ment: A Pharmaceutical Industry Prospective. J. Nat. Prod (1998) 61:1053–1071.
  • CRAGG GM, NEWMAN DJ, SNADER KM: Natural products in drug discovery and development. J. Nat. Prod. (1997) 60:52–60.
  • Fungal cell wall: Structure, synthesis and assembly. Ruiz- Herrera, JBoca Raton (Eds.), CRC Press (1992).
  • ••A monograph detailing a large body of knowledge concern-ing cell wall assembly.
  • Antifungal Drugs: (1, 3)13-Glucan Synthase Inhibitors. Selitrennikoff CP (Ed.), Landes and Co., USA (1995).
  • LIPKE P, OVALLE R: Cell wall architecture in yeast: new structure and new challenges. J. Bact. (1998) 180:3735–3740.
  • ••An excellent, brief review of a very recent model of cell wallstructure.
  • OSUMI M: The ultrastructure of yeast: cell wall struc-ture and formation. Micron. (1998) 29:207–233.
  • MADDEN K, SNYDER M: Cell polarity and morphogene-sis in budding yeast. Ann. Rev. Microbiol. (1998) 52:687–744.
  • TRINCI A, SAUNDERS P: Tip growth of fungal hyphae. Gen. Microbic)] (1977) 103:243–248.
  • SCOTT WA: Biochemical genetics of morphogenesis in Neurospora. Ann. Review Microbiol (1976) 30:85–104.
  • MISHRA N: Genetics and biochemistry of morphogene-sis in Neurospora. Adv. Genet. (1972) 19:341–405.
  • BULAWA C: Genetics and molecular biology of chitin synthesis in fungi. Ann. Rev. Microbiol. (1993) 47:505–534.
  • TAFT CT, SELITRENNIKOFF CP: LY121019 inhibits Neu-rospora crassa growth and (1, 3)-B-D-glucan synthase. Antibiot. (1988) 41:697–701.
  • BROWN JL, KOSSACZKA Z, JIANG B, BUSSEY H: A muta-tional analysis of killer toxin resistance in Saccharo-myces cerevisiae identifies new genes involved in cell wall (1, 6)-beta-glucan synthesis. Genetics (1993) 133:837–849
  • KLIS, F: Review: cell wall assembly in yeast. Yeast (1994) 10:851–869.
  • ••An excellent review of cell wall assembly in baker's yeast.
  • OGAWA K, WATANABE T, TSURUGI J, ONO S: Conforma-tional behaviour of a gel-forming 13-(1-3)-D-glucan in alkaline solution. Carbohydr. Res. (1972) 23:399–405.
  • TAKEDA H, YASUOKA N, KASAI N: X-ray structural stud-ies of (1-3)-D-glucan (curdlan). Polymer J. (1978) 10:365–368.
  • KLEBL F, TANNER W: Molecular cloning of a cell wallexo-p-1, 3-glucanase from Saccharomyces cerevisiae. Bacteriol. (1989) 171:6259–6294.
  • HARTLAND R, EMERSON G, SULLIVAN P: A secreted p-glucan-branching enzyme from Candida albicans. Proc. R. Soc. London Ser. B. (1991) 246:155–160.
  • KOPECKA M, KREGER D: Assembly of microfibrils invivo and in vitro from (1-3) p-D-glucan synthesized by protoplasts of Saccharomyces cerevisiae. Arch. Micro-bic)]. (1986) 143:387–395.
  • KRAINER E, STARK R, NAIDER F, ALAGRAMAM K, BECKER J: Direct observation of cell wall glucans in whole cells of Saccharomyces cerevisiae by magic angle spinning 13C-NMR. Biopolymers (1994) 34:1627–1635.
  • SARTHY A, MCGONIGAL T, COEN M et al.: Phenotype in Candida albicans of a disruption of the BGL2 gene en-coding a 1, 3-p-glucosyltransferase. Microbic)]. (1997) 143: 367–376.
  • GONZALEZ M, DIEZ-OREJAS F, MOLERO G et al: Pheno-typic characterization of a Candida albicans strain de-ficient in its major exoglucanase. Microbiology (1997) 143:3023-3032. DUJON B: The yeast genome project-what did we learn? Trends Genet. (1996) 12:263-270. GOFFEAU A: Life with 482 genes. Science (1995) 274:546-567. KOLLAR R, REINHOLD B, PETRAKOVA E et al.: Architec-ture of the yeast cell wall: (1, 6)p-glucan interconnects mannoprotein, p(1-3)-glucan, and chitin. J. Biol. Chem. (1997) 272:17762–17775.
  • DUJON B: The yeast genome project-what did we learn? Trends Genet. (1996) 12:263–270.
  • GOFFEAU A: Life with 482 genes. Science (1995) 274:546–567.
  • KOLLAR R, REINHOLD B, PETRAKOVA E et al.: Architecture of the yeast cell wall: (1, 6)b-glucan interconnects mannoprotein, b(1-> 3)-glucan, and chitin. J. Biol. Chem. (1997) 272:17762–17775.
  • KAPTEYN JC, MONTIJN RC, VINK E et al.: Retention of Saccharomyces cerevisiae cell wall proteins through a phosphodiester-linked p-1, 3-/p-1, 6-glucan hetero-polymer. Glycobiology (1996) 6:337–345.
  • KAPTEYN JC, MONTIJN RC, DIJKGRAAF P, KLIS F: Identifi-cation of p-1, 6-glucosylated cell wall proteins in yeast and hyphal forms of Candida albicans. Eur. J. Cell Biol. (1994) 65:402–407.
  • SURARIT R, GOPAL P, SHEPHERD M: Evidence for a gly-cosidic linkage between chitin and glucan in the cell wall of Candida albicans. J. Gen. Microbiol (1988) 134:1723–1730.
  • MEADEN P, HILL K, WAGNER J et al.: The yeast KRE5 geneencodes a probable endoplasmic reticulum protein re-quired for (1-6)-p-D-glucan synthesis and normal cell growth. Mol. Cell. Biol (1990) 10:313–3019.
  • CID V, DURAN A, DEL RAY F et al: Molecular basis of cellintegrity and morphogenesis in Saccharomyces cere-visiae. Microbiol. Rev. (1995) 59:345–386.
  • BOONE C, SDICU A, LAROCHE M, BUSSEY H Isolation from Candida albicans of a functional homologue of the Saccharomyces cerevisiae KRE1 gene which is involved in cell wall beta glucan synthesis. J. Bacteriol (1991) 173:6859–6864.
  • MIO T, YAMADA-OKABE T, YABE T et al: Isolation of theCandida albicans homologues of Saccharomyces cerevisiae KRE6 and SKN1: Expression and physio-logical function. J. Bacteriol (1997) 179:2363–2372.
  • LUSSIER M, SDICU A, SHAHINIAN S, BUSSEY H: The Can-dida albicans KRE9 gene is required for cell wall p-1, 6-glucan synthesis and is essential for growth on glucose. Proc. Natl. Acad. Sci. USA (1998) 95:9825–9830.
  • MAGLIANI W, CONTI S, GERLONI M, BERTOLOTTI D, POLONELLI L: Yeast Killer Systems. Clin. Microbiol Rev. (1997) 10:369–400.
  • Ostroff, G. (1998). p1, 6 Glucan Synthesis and Cell Wall Assembly. US Patent pending.
  • BARTNICKI-GARCIA S: Cell wall chemistry, morpho-genesis and taxonomy of fungi. Ann. Rev. Microbiol (1968) 22: 87–108.
  • WESSELS J, SIETSMA J: Fungal cell walls: a survey. In: Plant Carbohydrates (Edition 2). Tanner W, Loeewus F (Eds.), Springer-Verlag, Berlin, Germany (1980:352–394.
  • DOUGLAS C, MARRINAN J, LI W, KURTZ M: A Saccharo-myces cerevisiae mutant with echinocandin resistant 1, 30-D-glucan synthase. j Bacteriol (1994) 176:5686–5696.
  • •The first report of cloning the catalytic subunit of (1, 3)13-gl-ucan synthase.
  • DOUGLAS C, FOOR F, MARRINAN J, MORIN N, NIELSEN J et al.: The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1, 3-p-D-glucan synthase. Proc. Natl. Acad. Sci. USA (1994) 91:12907–12911.
  • CABIB E, DRGONOVA J, DRGON T: Role of small G-proteins in yeast cell polarization and wall biosynthe-sis. Ann. Rev. Biochem. (1998) 67:307–333.
  • ••An outstanding recent review of the role of G-proteins inwall assembly and (1, 3)13-glucan synthesis.
  • MAZUR P, MORIN N, BAGINSKY W, EL-SHERBEINI M, CLE-MAS J et al.: Differential expression and function of two homologous subunits of yeast (1, 3)p-D-glucan syn-thase. Mol. Cell. Biol. (1995) 15:5671–5681.
  • SELITRENNIKOFF CP: Inhibitors of (1, 3) p-glucan syn-thase. In: Design of Enzyme Inhibitors as Drugs. Sandler M, Smith H (Eds.), Oxford Science Publications (1994).
  • BARTIZAL K, ABRUZZO G, TRAINOR C et al.: In vitro anti-fungal activities and in vivo efficacies of 1, 3--D-glucan synthesis inhibitors L-671, 329, L-646, 991, tetrahy-droechinocandin B and L-687, 781, a papulacandin. An-timicro. Agents Chemother. (1992) 36:1648–1657.
  • KURTZ M, DOUGLAS C: Lipopeptide inhibitors of fun-gal glucan synthase. J. Med. Vet. Mycol (1997) 35:79–86.
  • BALKOVEC J: Lipopeptide antiftmgal drugs. Exp. Opin. Invest. Drugs (1994) 3:65–82.
  • OSTROFF G: (1, 3)-p-Glucan microfibril assembly assay. US Patent pending, 1998.
  • VANNI G, POLI F, DONINI A, PANCALDI S: Effects of Congo red on wall synthesis and morphogenesis in Saccharomyces cerevisiae. Plant Sci. Letters. (1983) 31:9–17.
  • MELLADO E, AUFAUVRE-BROWN A, SPECHT C, ROBBINS P, HOLDEN D: A multigene family related to chitin syn-thase genes of yeast in the opportunistic pathogen As-pergillus fumigatus. Mol. Genet. (1995) 246:353–359.
  • KATZ D, ROSENBERGER R: A mutation in Aspergillus nidulans producing hyphal walls which lack chitin. Biochim. Biophys. Acta. (1970) 208:452–460.
  • LELOIR L, CARDINI C: The biosynthesis of glucosamine.Biochim. Biophys. Acta. (1953) 12:15–22.
  • SELITRENNIKOFF CP, SONNEBORN D: Post-translationalcontrol of de novo cell wall formation during Blasto-cladiella emersonii zoospore germination: Feedback regulation of Hexosamine biosynthesis. Develop. Biol. (1976) 54:37–51.
  • SELITRENNIKOFF C, SONNEBORN D: The last two pathway-specific enzyme activities of hexosamine biosynthesis are present in Blastocladiella emersonii zoospores prior to germination. Biochim. Biophys. Acta. (1976) 451:408–416.
  • ETCHEBEHERE L, SIMON M, CAMPANHA R et al.: Devel-opmental regulation of hexosamine biosynthesis by protein phosphatases 2A and 2C in Blastocladiella em-ersonii. j Bacteriol (1993) 175:5022–5027.
  • MCKNIGHT G, MUDRI S, MAHEWES S et al.: Molecularcloning, cDNA sequence and bacterial expression of human glutamine:fructose-6-phosphate amidotrans-ferase. J. Biol. Chem. (1992) 267:25208–25212.
  • ETCHEBEHERE L, DA COSTA MAIA J: Phosphorylation-dependent regulation of amidotransferase during the development of Blastocladiella emersonii. Arch. Bio-chem. Biophys. (1989) 272:301–310.
  • WATZELE G, TANNER W: Cloning of the gluta-mine:fructose-6-phosphate amidotransferase gene from yeast. J. Biol. Chem. (1989) 264:8753–8758.
  • ENDO A, KAKIKI K, MISATO T: Feedback inhibition ofglutamine fructose 6-phosphate amidotransferase by uridine diphosphate N-Acetylglucosamine in Neuro-spora crassa. j Bacteriol. (1970) 103:588–594.
  • SELITRENNIKOFF CP, SONNEBORN DR: Regulation of the hexosamine biosynthetic pathway in the water mould Blastocladiella emersonii: Sensitivity to end-product inhibition is dependent upon the life cycle phase. Proc. Natl. Acad. Sci. USA (1980) 77:5998–6002.
  • RUSSELL P, SRB A: A study of glutamine:fructose-6-phosphate amidotransferase in certain developmen-tal mutants of Neurospora crassa. Molec. Gen. Genet. (1974) 129:77–86
  • MILEWSKI S, ANDRUSZKIEWICZ R, KASPRAZAK L et al.:Mechanism of action of anticandidal dipeptides con-taining inhibitors of glucosamine-6-phosphate syn-thase. Antimicrob. Agents Chemo. (1991) 35:36–43.
  • SELITRENNIKOFF C, OSTROFF G: Inhibitors of Ketol-Isomerase. (1998) US Patent pending.
  • PAYNE J, SHALLOW D: Studies on drug targeting in the pathogenic fungus Candida albicans: peptide trans-port mutants resistant to polyoxins, nikkomycins and bacilysin. FEMS Microbiol. Newslet. (1985) 28:55–60.
  • BECKER J, MARCUS S, TULLOCK J et al.: Use of the chitin-synthesis inhibitor nikkomycin to treat disseminated Candidiasis in mice. J. Infec. Dis. (1988) 157: 212–214.
  • FALKE J, BASS R, BUTLER S, CHERVITZ S, DANIELSON M:The two-component signalling pathway of bacterial chemotaxis. Ann. Rev. Cell Dev. Biol. (1997) 13:457–512.
  • LOOMIS W, SHAULSKY G, WANG N: Histidine kinases in signal transduction pathways of eukaryotes. J. Cell Sci. (1997) 110:1141–1145.
  • WURGLER-MURPHY S, SAITO H: Two-component signal transducers and MAPK cascades. TIBS (1997) 22:172–176.
  • MADHANI H, FINK G: The controls of filamentous dif-ferentiation and virulence in fungi. Trends Cell Biol. (1998) 8:348–353.
  • BREWSTER J, DE VALOIR T, DWYER N, WINTER E, GUSTIN M: An osmosensing signal transduction pathway in yeast. Science (1993) 259:1760–1763.
  • MAEDA T, WURGLER-MURPHY S, SIATO H: A two-component system that regulates an osmosensing MAP kinase in yeast. Science (1994) 369:242–245.
  • OTA I, VARSHARVSKY A: A yeast protein similar to bac-terial two-component regulators. Science (1993) 262:566–569.
  • MADHANI H, FINK G: The riddle of MAP kinase specific-ity. TIC (1998) 14:151–156.
  • SAN JOSE C, MONGER, PERES-DIAZ R, PLA J, NOMBELA C: The mitogen-activated protein kinase homology HOG1 gene controls glycerol accumulation in the pathogenic fungus Candida albicans. I Bacteriol. (1996) 178:5850–5852.
  • THOMASON P, TRAYNOR D, CAVET G, CHANG W, HAR-WOOD A, KAY R: An intersection of the cAMP/PKA and two-component signal transduction systems in Dirty-ostelium. EMBO J (1998) 17:2838–2845.
  • ANJARD C, ZENG C, LOOMIS W, NELLEN W: Signal trans-duction pathways leading to spore differentiation in Dictyostelium discoideum. Devel. Biol. (1998) 193:146–155.
  • ROBINSON M, COBB M: Mitogen-activated protein ki-nase pathways. Curr. Opin. Cell Biol. (1997) 9:180–186.
  • SIDERIUS M, ROTS E, MAGER W: High-osmolarity signal-ling in Saccharomyces cerevisiae is modulated in a carbon-source dependent fashion. Microbic)]. (1997) 143:3241–3250.
  • MORGAN B, BOUQUIN N, JOHNSTON L: Two-component signal-transduction systems in budding yeast MAP a different pathway? Trends Cell Biol. (1995) 5:453–457.
  • SCHUMACHER M, ENDERLIN C, SELITRENNIKOFF CP: The osmotic-/ locus of Neurospora crassa encodes a puta-tive histidine kinase similar to osmosensors of bacte-ria and yeast. Current Microbiol. (1997) 34:340–347.
  • ALEX L, BORKOVICH K, SIMON M: Hyphal development in Neurospora crassa: Involvement of a two-component histidine kinase. Proc. Natl. Acad. ScL USA (1996) 93:3416–3421.
  • ALEX L, KORCH C, SELITRENNIKOFF CP, SIMON M: COSI, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen, Candida albicans. Proc. Natl. Acad. ScL USA (1998) 95:7069–7073.
  • CALERA J, CHOI G, CALDERONE R: Identification of a pu-tative histidine kinase two-component phosphorelay gene (CaHK1) in Candida albicans. Yeast (1998) 14:665–674.
  • NAGAHASHI S, MIO T, ONO N et al: Isolation of CaSLN1 and CaNIK1, the genes for osmosensing histidine ki-nase homologues, from the pathogenic fungus Can-dida albicans. Microbic)]. (1998) 144:425–432.
  • HUNTER T, PLOWMAN G: The protein kinases of bud-ding yeast: six score and more. TIBS (1997) 22:18–22.
  • ERREDE B, LEVIN DE: A conserved kinase cascade for MAP kinase activation in yeast. Cur. Opin. Cell Biol. (1993) 5:254–260.
  • LEVIN DE, FIELDS FO, KUNISAWA R et al: A candidate protein kinase C gene, pkcl, is required for the S. cere-visiae cell cycle. Cell (1990) 62:213–224.
  • LEVIN DE, BARLETT-HEUBUSCH E: Mutants in the S. cerevisiae pkcl gene display a cell cycle-specific os-motic stability defect. J. Cell Biol. (1992) 116:1121–1129.
  • PARAVICINI G, COOPER M, FRIEDLI L et al: The osmotic integrity of the yeast cell requires a functional pkcl gene product. Mol Cell Biol. (1992) 12:4896–4905.
  • PARAVICINI G, MENDOZA A, ANTONSSON B et al TheCandida albicans pkcl gene encodes a protein kinase C homologue necessary for cellular integrity but not dimorphism. Yeast (1996) 12:741–756.
  • KAMADA Y, QADOTA H, PYTHON CP et al.: Activation of Yeast Protein Kinase C by Rhol GTPase. J. Biol. Chem. (1996) 271:9193–9196.
  • BUSSEY H: Cell Shape Determination a Pivotal Role for Rho. Science (1996) 272:224–225.
  • NONAKA H, TANAKA K, HIRANO H et al.: A downstream target of rhol small GTP-binding protein is pkcl, a homologue of Protein Kinase C, which leads to activa-tion of the MAP Kinase Cascade in Saccharomyces cerevisiae. EMBO J (1995) 14:5931–5938.
  • ROEMER T, PARAVICINI G, PAYTON MA et al: Characteri-zation of the yeast (1, 6)-pglucan biosynthetic compo-nents, Kre6p and Sknlp, and genetic interactions between the pkcl pathway and extracellular matrix assembly. J. Cell Biol. (1994) 127:567–579.
  • ANTONSSON B, MONTESSUIT S, FRIEDLE L et al.: Protein Kinase C in Yeast: Characteristics of the Saccharomy-ces cerevisiae pkcl gene product. J. Biol. Chem. (1994) 269:16821–16828.
  • YARDEN O, PLAMMANN M, EBBOLE DJ, YANOFSKY C: cot-/, a gene required for hyphal elongation in Neuro-spora crassa, encodes a protein kinase. EMBO (1992) 11(6) :2159–2166.
  • VERDE F, WILEY D, NURSE P: Fission yeast orb6, a ser/thr protein kinase related to mammalian rho ki-nase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell mor-phogenesis with the cell cycle. Proc. Natl. Acad. Sci. (1998) 95:7526–7531.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.